TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
HUMA

Humacyte Inc

Healthcare · Biotechnology

0.5856$ +1.8% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet HUMA
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
56.3% 38.9% 80.0% 75.5% 64.9% 34.7% 58.3%
55.6% 37.4% 75.9% 73.3% 62.7% 32.6% 43.4%
55.6% 37.4% 78.7% 74.3% 62.7% 32.6% 43.4%
0.4% 0.1% 0.1% 0.0% 0.0% 0.0% 0.4%
0.0% 0.0% 0.0% 0.0% 0.0% 11.7%
43.7% 61.1% 12.2% 14.7%
21.6% 33.8% 57.4% 42.8% 89.4% 138.2% 97.3%
6.4% 10.5% 3.9% 9.6% 14.4% 14.5% 15.8%
1.8% 4.0% 0.7% 5.3% 2.0% 2.1% 2.1%
1.9% 2.1% 0.7% 0.8% 5.1% 3.3% 4.6%
0.8% 9.5% 10.0% 30.1% 30.5%
78.4% 66.2% 42.6% 57.2% 10.6% -38.2% 2.7%
-190.6% -363.8% -144.7% -208.8% -419.0% -497.6% -624.6%
61.1% 11.7% 13.9% 50.4% 80.7% 85.9% 135.9%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?